Neuland Laboratories Q2 Results
- BSE: 524558
- NSE: NEULANDLAB
- ISIN: INE794A01010
- Sector: Major Drugs
BSE
14,872.95
-31.30 (-0.21%)
-31.30 (-0.21%)Volume644.00
Updated: Mon 25 Nov, 2024 | 15:49:14
NSE
14,853.95-51.00 (-0.34%)
-51.00 (-0.34%)Volume32.98 K
Updated: Mon 25 Nov, 2024 | 15:43:10
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
- Total Income₹310.84 Cr.(-29.29%)
- Operating Profit₹46.15 Cr.(-63.86%)
- Profit After Tax₹32.84 Cr.(-66.44%)
- Operating Margin14.85%(-49.56%)
Note: Comparison is on YoY basis
Quarterly - Neuland Laboratories Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 24 | Jun 23 | QoQ Comp | Sep 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 310.84 | 362.99 | -% | 417.75 | -% |
| Selling/ General/ Admin Expenses Total | 63.07 | 59.89 | -% | 68.96 | -% |
| Depreciation/ Amortization | 16.07 | 13.59 | -% | 14.51 | -% |
| Other Operating Expenses Total | 25.79 | 22.58 | -% | 19.72 | -% |
| Total Operating Expense | 264.69 | 279.66 | -% | 294.77 | -% |
| Operating Income | 46.15 | 83.33 | -% | 122.98 | -% |
| Net Income Before Taxes | 49.42 | 83.16 | -% | 121.59 | -% |
| Net Income | 32.84 | 61.88 | -% | 89.25 | -% |
| Diluted Normalized EPS | 25.60 | 48.23 | -% | 69.56 | -% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
- Markets
01NTPC Green Energy IPO allotment date likely today. GMP, how to check status online
2 min read07:58 AM IST - Markets
02Buy or sell: Sumeet Bagadia recommends three stocks to buy on Monday — Nov 25
4 min read06:15 AM IST - Markets
03Enviro Infra Engineers IPO day 2: GMP jumps; subscription status, review, apply or not?
3 min read03:07 PM IST